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1) RESEARCH ACTIVITY INFORMATION 
 
a) Title of Research Activity: “Pharmacological & Physiological Characterisation of the 
Rat Mammary Artery at Different Stages of Reproduction” 
 
b) Principal Investigator: Dr Iain F Gow 
 
c) Named Investigators:  Mr David Blatchford (1st April 2006 – 31st December 2007), and 
Dr Duncan Macgregor (1st January 2008 – 31st March 2009) 
 
d) Reporting period: 1st April 2006 – 31st March 2009 
 
 
2) EXECUTIVE SUMMARY 
a) Summary of Research Activity:  
The overarching-aim of the project was to assess the responsiveness of the rat mammary 
artery during different stages of the reproductive cycle.   This has implications for not only 
normal physiology, but also heart disease, since women who undergo coronary artery bypass 
surgery using mammary arteries as the conduit and who have breastfed their offspring have a 
significantly better prognosis that those who have never breastfed.    
The first major achievement of the project was the establishment of a breeding colony of 
rats.  This took much longer than expected since initially, the rate of pregnancy was very 
low, and due to the need for randomisation, the optimum colony mass was not achieved until 
several months after arriving at Strathclyde.  However having overcome the complexity of 
organising such a colony, we are now very well placed to perform other studies where 
randomised states of reproduction are required. 
Experimental results showed that the artery preparations were much more variable than 
other similar vessels, possibly because of a high intrinsic tone.  This variability meant more 
observations (up to 19 in some instances) were required to be able to detect significant 
differences (if present).  Preliminary experiments showed that the arteries responded to 
noradrenaline and serotonin, but bearing in mind the increased numbers of observations 
required, we concentrated in assessing responses mediated by noradrenergic receptors.  Use 
of  contractile agents relatively specific for certain receptors indicated that contract was 
mediated by alpha, most likely predominantly alpha1/1A receptors since drugs acting at those 
receptors caused contraction at all stages of the reproductive cycle. 
  Arteries from animals undergoing the reproductive cycle contracted more strongly in the 
presence of known contractile agents than the controls.  Conversely, timed-control animals 
from the lactation period showed relaxation with an alpha2 agonist (UK 14,304) whereas the 
reproducing animals did not.   The artery luminal area was greater in lactating animals than 
controls, and more muscle was present in pregnant/lactating RMAs than controls. 
We demonstrated that single vascular smooth muscle cells could be isolated from the rat 
mammary artery.   Most of the proposed work was completed, with modifications to the 
project being made to take into account the changes in personnel.  We conclude that 
functional changes do occur in the RMA during the reproductive cycle, and these are 
accompanied by structural changes of the vessel.  Vessels from animals post-weaning 
contracted more strongly than those from controls, suggesting reproduction does produce 
changes in vascular responsiveness which are retained long after lactation has ceased.   
  
However there is a paradox requiring further investigation which is that at a time when most 
muscle is present (lactation), the contractile force generated appears to be at its lowest. 
b) Summarised Main Objectives: 
i) Characterisation of the receptor profile of the Rat Mammary Artery (RMA) 
ii) Assessment of mechanisms of differences in the RMA at different stages of the 
reproductive cycle (virgin, pregnant, peak lactation, and post-weaning).  
iii) Determine changes in the RMA following treatment of non-pregnant female rats with 
synthetic oestrogen and progesterone to mimic pregnancy 
 
3) INTRODUCTION TO THE RESEARCH ACTIVITY AND BACKGROUND 
INFORMATION 
 
a) Overall aims of the Research Activity, background and objectives:   This project 
proposed to study the behaviour of the rat mammary artery (RMA) model, to assess 
changes occurring during the reproductive cycle.   In breast cancer, it is known that a 
single pregnancy and breastfeeding protects the mother against the disease to a certain 
extent, though the mechanism of this remains unknown.    Permanent changes occur in 
the blood vessels of the breast when women have breastfed their offspring, and this could 
result in an increased blood and oxygen supply to the gland, and faster removal of toxins, 
both of which may be protective against tumour establishment or proliferation.   By 
characterising the behaviour of the RMA more fully at different stages of the 
reproductive cycle, we will  be able to see if any observed changes are retained once milk 
production has stopped.   One of the mechanisms put forward to explain these changes 
has been that exposure of the mammary gland to the levels of reproductive hormones 
found in pregnancy confers protection on the gland; the supported project sought to 
examine the vascular responses in the mammary gland under controlled conditions of 
reproduction.  The major objectives where thus to examine the mammary artery 
responsiveness during the reproductive cycle, and seek evidence that changes occurred 
were retained after weaning. 
 
b) Staff employed on the project: 
i) Dr Iain F Gow (1st April 2006 – 30th November 2007) 
ii) Mr David Blatchford (1st April 2006 – 31st December 2007) 
iii) Dr Duncan Macgregor (1st January 2008 – 31st March 2009) 
 
c) Timetable and milestones as in original proposal: the original proposal did not include 
a timetable or milestones 
 
d) Any major changes in the Research Activity: due to the loss of a senior researcher 
from the project (IFG) and the changeover in research associate (DB to DMcG), we could 
not perform the hormonal implant, receptor identification, or ion-flux studies in this 
project.  However the information gathered from the SEERAD-funded project has 
enabled us to submit a strong application to the BBSRC to pursue areas not addressed 
(see Annex 10).  We chose therefore to concentrate on the functional measurements 
combined with histological data assessing any physical changes in the artery which might 
account for this. 
 
4) RESULTS - Vessel contractions/relaxations obtained using noradrenaline (NA – alpha/beta 
agonist), phenylephrine (PE – alpha1 agonist), A61603 (alpha1A agonist), and UK 14, 304 
(alpha2 agonist) were measured by standard wire myography of isolated mammary vessels 
obtained from female rats.   Rat were selected from a colony established in such a way that 
animals (and age and sex-matched virgin controls – AMVCs) at different stages of the 
  
reproductive cycle were available in a statistically random manner.  The stages used were 
Pregnant (17 days from a mating at age seven weeks), Lactating (30 days after mating, 10-12 
after parturition), and Weaned (60 days after mating, 30 days after pup removal).   Data for 
myography were analysed by Graphpad Prism, groups contained between 8-20 animals.  For 
histology, isolated RMAs were fixed using 10% formaldehyde perfused at 100 mmHg to 
maintain the architecture of the vessel at in vivo pressures.  The arteries were then embedded 
in wax and stained with haematoxylin and eosin.  Cross-sectional images were captured 
using a digital camera, and measurements made using Motic Image Plus 2.0 software.   
Isolated vascular smooth muscle cells were prepared from RMA by gentle digestion with 
papain/collagenase.   Data were analysed with ANOVA (one- or two-way as appropriate) 
followed by the Student’s t test with Bonferroni post-hoc modification or standard t test as 
appropriate.   Data are presented in Annexes for reference.  The results overall indicate that 
functional changes occur in the rat mammary artery during the reproductive cycle, and that 
changes persist well after reproduction has ceased.   As far as we are aware, this is the first 
demonstration of such an effect in major mammary arteries, and is consistent with the 
hypothesis that pregnancy and lactation create permanent changes in breast physiology.   
These results are particularly exciting since they provide an excellent foundation from which 
to build and seek further funding to progress this extremely important area.   The project 
involved a great deal of assistance from and co-ordination with the university biomedical 
planning unit, biophotonics, and the cardiovascular research group.  These well-established 
groups assisted greatly in ensuring the project started as quickly as possible, and that 
resources were available for the research.  In summary, major findings/outcomes were: 
 
• A colony capable of regularly providing animals at various stages of reproduction in a 
statistically random manner was established 
• RMAs responded in a dose-dependent manner to all the above agonists, contracting 
with most, but relaxing with UK 14, 304 (Annexes 1,2) 
• There was no change in sensitivity to the contractile agents, but the controls showed a 
significant increase in sensitivity to UK 14, 304 at around day 30 as measured by the 
pEC50 (Annexes 3-5) . 
• RMA contractions with NA, A61603, and PE were all greater in the reproducing 
animals than the AMVCs (Annex 6) 
• RMA contractions with NA and PE were greater in weaned animals than AMVCs 
(Annex 6) 
• RMA contractions with PE were greater in pregnant animals than AMVCs (Annex 6) 
• RMA contractions with PE were greater in weaned compared with lactating rats 
(Annex 6) 
• RMA relaxations were greater in AMVCs at day 30 compared with day 17 (Annex 6) 
• the RMA luminal area in lactating rats is greater than pregnant, weaned, or AMVCs of 
any age (Annexes 7 - 8) 
• the cross-sectional area of muscle in RMAs from pregnant and lactating animals is 
greater than the corresponding AMVCs (Annexes 7 - 8) 
• the muscle:lumen area ratio is less in lactating animals than the AMVC (Annexes 7 - 8) 
• viable vascular smooth muscle cells could be isolated from RMA by gentle digestion 
with papain/collagenase (Annex 9) 
 
There are a great many benefits arising from the transitional funding: it has allowed us to 
consolidate and further develop an unique model first established at the Hannah.  We have made 
significant progress in an area of research which we believe is not only extremely important from 
the biological stance, but retains the spirit, philosophy and direction of work from the Hannah 
Institute.  The period of Transitional Funding has allowed two seniors researchers to gain 
substantive posts, and another to gain valuable experience in a range of cardiovascular 
  
techniques.  In addition, we managed to provide experience and training for both undergraduate 
and postgraduate students during this time.  Finally, and possibly most importantly, it has 
provided substantial data, some of which we have already used (Annex 10) in seeking other 
funding to continue and expand the research. 
 
5) CONCLUSIONS 
a) Main findings: 
The main findings indicate that physiological changes occur in the mammary gland blood 
vessels during reproduction, and the single cycle of reproduction seen here is enough to 
produce changes which persist for at least several months.  This is significant when it is 
considered that unknown changes persist in human and other animal mammary glands 
following a single pregnancy which confers a degree of protection against breast cancer.  To 
date, the role of the blood supply has largely been ignored, attention being devoted almost 
exclusively to the mammary epithelial cell.  The results from this study shows that vascular 
changes may also play a role. 
There are several unanswered questions from the study: although functional changes have 
been observed, why is the strength of contraction weakest when the muscle mass is 
apparently greatest (i.e. peak lactation)?  Are there changes in receptor 
numbers/characteristics which could explain this?   The AMVCs were not expected to show 
differences between groups, yet the animals sacrificed on Day 30 were more sensitive to UK 
14, 304 than at the other time points.  This would not be due to seasonal/temporal effects 
since the culls were randomised throughout the year.  The AMVC contractions paralleled 
(but were always less than) the profiles of the reproducing animals.  Again, due to the 
randomisation of sampling, we feel able to exclude temporal effects.  It is particularly 
exciting that a study which we believe to be designed reasonably robustly has thrown up 
challenges which remain to be addressed by further studies. 
b) Consequences of findings from the Research Activity as a whole: 
The overall consequences of the Research Activity is that clearly reproduction has a 
significant, persistent effect on mammary artery tone.  Muscle mass increases, possibly 
through muscle cell hypertrophy or proliferation, but then decreases but with an increase in 
the force generated during contraction in response to alpha1 agonists.  Changes in size and 
blood flow in mammary arteries in women who have breastfed have been reported, and a 
history of breastfeeding has been associated with an improved prognosis in women 
undergoing coronary artery bypass using internal mammary arteries as conduits.   Thus it is 
clear that the functional changes of the mammary artery need to be investigated further, since 
a better understanding of the normal physiology of this vessel may have important 
applications in diseases such breast cancer or coronary heart disease. 
 
6) COMMUNICATED OUTPUTS 
a) Refereed Publications: “Blatchford, D & Gow, IF.  Contraction induced by noradrenaline 
or serotonin is increased in the rat superficial epigastric artery during lactation.” From the 
University of  Oxford, Winter 2006 Meeting: Proceedings of the British Pharmacological 
Society http://www.pa2online.org/abstracts/Vol4Issue2abst137P.pdf 
b) Popular and trade articles: none 
c) Presentations at scientific meetings: “Blatchford, D & Gow, IF.  Contraction induced by 
noradrenaline or serotonin is increased in the rat superficial epigastric artery during 
lactation.” British Pharmacological Society, University of  Oxford, Winter 2006 
d) Other reports/publications/communications: preliminary data used in BBSRC grant 
application 
e) Communication of research to the public: none 
f) Technology Transfer: none 
g) Patents applied for: none 
  
 
7) RESOURCES 
a) To follow, as per email from RERAD to University of Strathclyde dated the 17th 
February 
b) Investigators funded by this project, and related studentships: 
i) Dr Iain F Gow (Staff: 1st April 2006 – 30th November 2007) 
ii) Mr David Blatchford (Staff: 1st April 2006 – 31st December 2007) 
iii) Dr Duncan Macgregor (Staff:1st January 2008 – 31st March 2009) 
iv) Two third-year pharmacology students from Strathclyde (Ms Lisa Michel and Mr 
Peter Gordon) spent six weeks working in the laboratory at Strathclyde (June-July 
2007) on studies related to this project.  This stimulated their interest in research so 
much they are both now doing PhD degrees. 
v) An MRes student (Mr Ahmad Alsaadi) worked on some of the histological 
measurements, for which due acknowledgement is given. 
c) Other staff contributing to this project: none 
d) Destination of Principal Investigator and Investigators after the end of the Transitional 
Funding Grant: 
i) Dr Iain F Gow – indefinite contract as a Lecturer at Queen Margaret University, 
Edinburgh, from 1st December 2007 
ii) Mr David Blatchford – five-year contract as Biophotonics Technician, University of 
Strathclyde, from 1st December 2007 
iii) Dr Duncan Macgregor – awaiting outcome of BBSRC grant application submitted by 
Dr Gow, otherwise contract ends 31st March 2009 
 
8) ACKNOWLEDGEMENTS 
a) We acknowledge with great gratitude the assistance of RERAD/SEERAD in funding the 
project, and in particular the role of RERAD and other Ministers of the Scottish 
Government, and other Ayrshire MSPs in allowing flexibility in the original Terms and 
Conditions of the Grant in the case of Dr Gow (Principle Investigator, PI) who left to take 
up another post at Queen Margaret University, Edinburgh.   This flexibility had several 
benefits: 
i) savings were made since although the PI had transferred to another organisation’s 
funding, a significant proportion of the project was completed which would otherwise 
have been lost 
ii) it assisted cross-institutional collaboration 
iii) the project produced results which will assist in attracting other funding to continue 
Hannah science in Scotland 
iv) support staff jobs were not lost since the project was active until the agreed date 
v) the agreement of Ministers to allow transfer of  Dr Gow’s Transitional Funding 
Equipment means that Queen Margaret University has an excellent foundation from 
which to develop its biomedical research strategies 
  
 
9) ANNEXES 
 
a) Annex 1:  
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b) Annex 2: 
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c) Annex 3: 
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d) Annex 4 
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e) Annex 5: 
Noradrenaline
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f) Annex 6: 
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g) Annex 7 
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i) Annex 9 
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Objectives (mandatory) 
List the main objectives of the proposed research in order of priority [up to 4000 chars] 
Studies for the proposed project will use rodents undergoing normal reproduction as well as ovariectomised (rat/mouse) 
and oestrogen-receptor knock-out (mouse) models to allow control of circulating oestradiol and its targets. Ovariectomy 
followed by implantation of slow-release oestradiol (the major oestrogen in rodents) pellets will be used to replace the 
hormone levels appropriate for the stage of reproduction (i.e. late-pregnant, peak lacatation and weaned).   Expertise and 
methodologies for the proposed experiments are well-established in the cardiovascular and biophotonics laboratories at 
the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS). 
 
Objective 1 - Oestradiol and Mammary Artery Remodelling: 
A major objective is to investigate the degree and mechanisms of oestradiol-induced vascular remodelling of the 
mammary artery in the above groups by using proliferation assays applied to isolated vascular smooth muscle cells, and 
also with consideration of the distribution of specific vascular cell types measured by conventional histology, fluorescence 
immunohistochemistry, and dual-photon confocal microscopy.  
 
Objective 2 - Oestradiol and Vascular Smooth Muscle Cell (VSMC) Ion Regulation: 
We shall assess the interaction between endogenous oestradiol levels and Na+/H+ exchange activity in vascular smooth 
muscle cells isolated from the rodent mammary artery from the groups above. This involves the use of ion-sensitive 
fluorescent probes such as 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF) or fura-2 for H+ and Ca2+ 
measurement respectively, techniques we have used successfully in the past to measure free ions in isolated cardiac or 
mammary epithelial cells. 
 
Objective 3 -Oestradiol-induced Vascular Remodelling and Insulin-like Growth Factor 
The levels of IGF-1 and IGF-1 receptor (IGF-1R) will be assessed in the smooth muscle layer of mammary arteries 
excised from the different treatment groups by fluorescent immunohistochemistry to determine whether or not they 
change when the animals experience different levels of oestradiol in vivo. 
 
Objective 4 -Oestradiol and Mammary Artery Tone: 
This objective will determine the effect in terms of oestradiol levels on function of the rodent (i.e. rat or mouse) mammary 
artery by measuring changes in vascular tone in mammary arteries in response to classical alpha adrenoceptor agonists.   
This will be achieved in the above groups by standard wire myograph techniques we have already used in developing the 
rodent mammary artery model.  
Summary (mandatory) 
Describe the proposed research in simple terms in a way that could be publicised to a general audience [up to 4000 
chars] 
The mammary gland is a dynamic organ, varying with age, menstrual cycle and reproductive state; it develops in the 
associated fat pad around puberty, and undergoes massive development during pregnancy, preparing the gland for milk 
production during lactation. Blood flow to the mammary gland is important since mammary blood flow increases around 
and after parturition/lactation, with 16% or 12% of cardiac output being directed to the gland in cows or rodents 
respectively at peak lactation; mammary arteries adapt to this by increasing artery muscle thickness during lactation in 
rats, though whether this is due to an increase in cell number or size is unknown. In addition, little is known about the 
intrinsic ability of mammary arteries to regulate blood flow, and there is even less information about their functional 
changes during the reproductive cycle, when the gland undergoes major anatomical and physiological changes. 
Conversely, other vessels associated with the reproductive system such as uterine blood vessels have been well-studied, 
and are known to be desensitised to agonists during pregnancy.   Although studying the way reproduction changes 
mammary artery sensitivity and structure is interesting per se, there are also health-related benefits: in the UK, heart 
disease is still a major cause of mortality and morbidity, and human mammary arteries are used to bypass blocked 
cardiac arteries.   Overall, the survival rate for women is poorer after such operations, however in women who have been 
pregnant and have breast-fed their offspring, the prognosis is much better, since their mammary arteries are larger with 
greater blood flow.   Crucially, the reasons for these arterial changes are largely unknown, thus a better understanding of 
how reproductive hormones are involved in the "remodelling" of mammary arteries is not just of academic interest, but 
may be of use to those involved in such clinical procedures.   It is an appropriate time to seek further knowledge about 
interactions between reproductive hormones and vascular physiology: cardiovascular disease is still a major cause of 
death in women in the Western world, and scientific debate about the cardiovascular benefits or otherwise of hormone-
replacement therapy in peri-/postmenopausal women is still ongoing.   Hence clarification of some of the mechanisms 
linking vascular changes with levels of a major reproductive hormone are timely. 
This work is aimed at determining functional and physical changes in mammary arteries from rodents, and how these 
changes are affected by exposure to the major reproductive hormone in these models.   This proposal brings together 
and can draw on the expertise of staff at Queen Margaret and Strathclyde Universities whose backgrounds in mammary 
artery physiology, oestrogen biology, cardiovascular and growth factor function give a unique blend of skills which can be 
applied to this project.  The recent investment at Strathclyde in multi-photon technology in the biophotonics suite also 
allows ready access to world-class facilities which can be applied to the parts of the project dealing with changes in 
biological structure.   This project requires a dedicated experienced researcher at post-doctoral level to arrange, 
administer, and carry out the practical aspects to the research; in addition, use will be made of existing facilities such as 
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the excellent animal unit at Strathclyde which is experienced in setting up and maintaining a rodent colony which allows 
animals at particular stages to be selected in a randomised fashion.   It is anticipated that this work will not only advance 
basic scientific knowledge, but will also provide information about the mechanism of human mammary artery remodelling 
in women during pregnancy and breast-feeding, which may in turn lead to therapeutic manoeuvres which could 
pharmacologically remodel these vessels prior to surgery, thus improving the prognosis for women undergoing coronary 
artery bypass grafting. 
Technical Summary (mandatory) 
Describe the proposed research in a manner suitable for a specialist reader. This summary will be made publicly available 
if the proposal is funded. [up to 2000 characters] 
The demands of the mammary gland during the reproductive cycle vary from quiescence to peak lactation, & mammary 
blood flow is greatest at peak lactation. In our current RERAD-sponsored project, we are studying rat mammary artery 
(RMA) tone during the reproductive cycle & have found that the lowest contractile force was at peak lactation, when blood 
oestradiol levels are lowest. We also found histological evidence of changes in artery structure, with a decreased vascular 
muscle/lumen ratio at peak lactation. Oestradiol, the major oestrogen in the rat, may play a role in remodelling mammary 
vessels during the reproductive cycle: physiological levels of oestradiol increase vascular smooth muscle cell (VSMC) 
number, inhibit DNA synthesis, & decrease neointimal thickening following injury. This is significant since many other 
vascular effects of oestradiol such as Ca2+ mobilisation or vessel relaxation require pharmacological levels of the steroid. 
Many proliferative or hypertrophic agents initially stimulate Na+/H+ exchange (NHE), resulting in cytosolic alkalinisation 
which correlates with increased DNA synthesis. In addition, cytosolic alkalinisation is associated with increased 
contraction of vascular muscle. The mechanisms by which oestradiol affects vascular remodelling have not been defined, 
though cytosolic alkalinisation may play a part since low oestradiol concentrations stimulate NHE activity in VSMC, 
whereas higher levels inhibit it. We postulate that the ability of oestradiol to modulate VSMC NHE may be pivotal to the 
anatomical and functional changes occurring in the RMA during reproduction. Thus our aim is to mimic the effects of 
reproduction by pharmacological manipulation of  blood oestradiol in ovariectomised rodents using continuous-release 
pellets, & compare those responses with animals undergoing normal reproduction. Use of  genetically-altered animals will 
allow us to assess the contribution of classical estrogen receptors. 
Beneficiaries (mandatory) 
Describe who will benefit from the research [up to 4000 character] 
This proposal is aimed at identifying fundamental mechanisms involved in the interaction between oestradiol and the 
mammary artery during different reproductive states, and it is not anticipated that there will any immediate benefit to end-
users in the short-term.   However the information gained may be of use to those investigating the role of oestradiol in 
hormone replacement therapy, or vascular changes related to ageing in women.   In addition, the novel animal model 
used in this proposal is also of potential interest to health care professionals using coronary artery bypass grafting 
(CABG), since the human internal mammary artery (HIMA) is still the conduit of choice for this technique, and there are 
clear differences in suitability of this vessel between women who have breast-fed, and those who have not.   Information 
obtained from this proposal can be used to justify similar though non-invasive studies in humans, and how oestrogen 
status may impact on peri- and postoperative complications or timing of operations when using HIMA.    In addition, if 
hormone-mediated vascular remodelling can be demonstrated, this opens up the possibility of pharmacological 
interventions in suitable candidates prior to surgery to aid vessel patency and patient prognosis, thus results of the 
research would be of interest to pharmaceutical and surgical colleagues.   As far as we are aware, we are the only group 
in the UK and possibly elsewhere studying this rodent vessel in this way. Further development and knowledge of our 
model would make it a useful adjunct to justify research related to the suitability of HIMA in different groups of patients; for 
example, it has recently been shown that HIMAs from diabetic patients are more responsive to stimulation than 
nondiabetic patients. Our model could be used to examine the underlying cellular mechanisms for this and, similar 
situations, thus an in-depth understanding of the normal biology of the artery in an animal model is essential, and may 
ultimately lead to increased clinical interest in mammary artery physiology.   This project will allow the present post-
doctoral research fellow to expand his experience from basic myography and histology into cellular ion measurements 
and fluorescent/confocal imaging in an Institute with world-class facilities and expertise in these areas.   For these 
reasons, this proposal provides an excellent opportunity for the post-doctoral researcher to be at the forefront of research 
in an exciting and expanding area, and to develop and increase his transferable skills by acquiring expertise in sought-
after techniques such as confocal microscopy and digital image analysis.   Research by the Cardiovascular Group at 
Strathclyde is internationally competitive, thus experience within this group and successful completion of this project with 
the expected publications will place him in an excellent position to develop his own future research, and he will be well-
placed to apply for further academic posts and supportive grants in his own right.   This will also strengthen the 
Cardiovascular Group's reputation in this important yet neglected area, and further enhance the standing of the 
Strathclyde Institute as a centre of excellence in contemporary biomedical research. 
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Summary of Resources Required for Project 
  
Financial resources 
Summary 
fund 
heading 
Fund 
heading 
Full 
economic 
Cost 
BBSRC 
contribution 
% BBSRC 
contribution 
Directly 
Incurred Staff 0.00 0.00 80
 Travel & Subsistence 1600.00 1280.00 80
 Equipment 0.00 0.00 80
 Other Costs 200.00 160.00 80
  Sub-total 1800.00 1440.00  
     
Directly 
Allocated Investigators 11490.00 9192.00 80
 Estates Costs 1210.00 968.00 80
 
Other 
Directly 
Allocated 
0.00 0.00 80
  Sub-total 12700.00 10160.00  
     
Indirect 
Costs 
Indirect 
Costs 5950.00 4760.00 80
     
  Total 20450.00 16360.00   
 Summary of staff effort requested 
 Months 
Investigator 2.5 
Researcher 0 
Technician 0 
Other 0 
Visiting Researcher 0 
Student 0 
Total 2.5  
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Joint Proposals 
Complete this section if more than one organisation is submitting a BBSRC proposal form for this project. 
Is this part of a joint proposal ? 7Yes No  
Are you the lead RO ? 7Yes No  
Joint reference H784805 
Total number of proposals 2 
Research Councils / MoD Joint Research Grants Scheme (JGS) 
If MoD/DSTL have indicated that they are prepared to provide support for this proposal if successful, please indicate the 
percentage level of this support and MoD/DSTL contact details. 
Percentage funding indicated by 
DSTL DSTL contact 
DSTL Reference (a  letter providing this 
reference is attached with the Case for 
Support) 
   
Other Support 
Details of support sought or received from any other source for this or other research in the same field. 
Awarding 
Organisation 
Awarding 
Organisation’s 
Reference 
Title of project 
Decision 
Made 
(Y/N) 
Award 
Made 
(Y/N) 
Start Date End Date 
Amount 
Sought/Awarded 
(£) 
Scottish 
Executive 
Env and 
Rural Affairs 
2006 
Pharmacological 
& Physiological 
Characterisation 
of the Rat 
Mammary Artery 
Y Y 01/04/2006 31/03/2009 549000 
Related Proposals 
Proposal is related to a previous proposal to BBSRC 
Reference Number How related? 
  
Related Grants 
Provide the BBSRC reference numbers of any current grants held by any of the applicants that 
are related to this proposal.  
Interim reports of these grants should be submitted with this proposal. 
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Staff 
Directly Incurred Posts 
   EFFORT ON PROJECT       
Role Name /Post Identifier Start Date 
Period 
on 
Project 
(months)
% of 
Full 
Time 
Scale Increment Date 
Basic 
Starting 
Salary 
London 
Allowance 
(£) 
Super-
annuation 
and NI (£) 
Total cost 
on grant (£) 
           
           
           
 Total 0 
Applicants 
Role Name 
Post will 
outlast 
project 
(Y/N) 
Contracted 
working week as 
a % of full time 
work 
Total number of hours to 
be charged to the grant 
over the duration of the 
grant 
Average number 
of hours per week 
charged to the 
grant 
Rate of 
Salary 
pool/banding 
Cost estimate 
        
Principal 
Investigator Dr Iain Gow Y 100 330 3.8 57450 11490 
 Total 11490 
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Equipment  (the cumulative value of equipment over £50,000 will be treated as an exception) 
Description Country of Manufacture 
Delivery 
Date 
Basic 
price £ 
Import 
duty £ VAT £ Total £ 
       
 Total £ 0 
Travel and Subsistence 
Destination and purpose Total £ 
Within 
UK 40 site lab vists @ 100 miles per visit 1440
Within 
UK Parking costs - 40 x £4 160
Total £ 1600
Other Directly Incurred Costs 
Description Total £ 
Consumables 200 
Total £ 200 
Other Directly Allocated Costs 
Description Total £ 
 0 
Total £ 0 
Research Facilities/Existing Equipment 
Description Total £ 
 0 
Total £ 0 
Animal Costs 
Animal 
Species 
Type and 
Microbiological 
Quality 
Genetically 
Altered? 
No.  
Purchased 
Average 
Cost per 
Animal (£)
No. 
Bred 
Average 
Cost per 
Animal 
(£)
Maintenance 
duration 
(weeks) 
Weekly 
Maintenance 
costs per 
Species (£)
Total Cost 
£
          
Total £ 0
Research Council Facilities 
  
Name of Facility Proposed Usage 
  
Project Partners: details of partners in the project and their contributions to the research.  These contributions are in 
addition to resources identified above. 
 Name of partner organisation Division or Department Name of contact 
   
Direct contribution to project Indirect contribution to project 
 Description Value £  Description Value £
cash   
use of 
facilities/ 
equipment
  
equipment/materials   staff time   
secondment of staff   other   
other   Sub-Total   
Sub-Total    Total Contribution  
 
Total Contribution from all Project 
partners £0
Ethical Information (mandatory) 
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  Please answer the following questions as appropriate 
 
a) Human Participation 
 
Would the project involve the use of human subjects? Yes No7 
 If yes, would equal numbers of males and females be used? Yes No7 
Would the project involve the use of human tissue? Yes No7 
Would the project involve the use of biological samples? Yes No7 
Would the project involve the administration of drugs, chemical agents or vaccines to 
humans? Yes No7 
Will personal information be used? Yes No7 
 If yes, will the information be anonymised and unlinked? Yes No7 
 Or will it be anonymised and linked? Yes No7 
 Will the research participants be identifiable? Yes No7 
 
b) Animal Research 
 
Would the project involve the use of vertebrate animals or other organisms covered by 
the Animals (Scientific Procedures) Act? Yes7 No 
 If yes, what would be the severity of the procedures? Mild  
  Moderate 7 
  Substantial  
 Please provide details of any areas of substantial or moderate severity: 
 Ovariectomy and implantation of oestradiol pellets by trochar 
 
c) Genetic and Biological Risk 
 
Would the project involve the production and/or use of genetically modified animals? Yes7 No 
 If yes, will genetic modification be used as an experimental tool, e.g., to study the function of a gene in a genetically modified organism? Yes7 No 
 And will the research involve the release of genetically modified organisms? Yes No7 
 And will the research be aimed at the ultimate development of commercial or industrial genetically modified products or processes? Yes No7 
Would the project involve the production and/or use of genetically modified plants? Yes No7 
 If yes, will genetic modification be used as an experimental tool, e.g., to study the function of a gene in a genetically modified organism? Yes No7 
 And will the research involve the release of genetically modified organisms? Yes No7 
 And will the research be aimed at the ultimate development of commercial or industrial genetically modified products or processes? Yes No7 
Would the project involve the production and/or use of genetically modified microbes? Yes No7 
 If yes, will genetic modification be used as an experimental tool, e.g., to study the function of a gene in a genetically modified organism? Yes No7 
 And will the research involve the release of genetically modified organisms? Yes No7 
 And will the research be aimed at the ultimate development of commercial or industrial genetically modified products or processes? Yes No7 
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d) Approvals 
 
Have the following necessary approvals been given by:    
 The Regional Multicentre Research Ethics Committee (MREC) or Local Research Ethics Committee (LREC)? Yes No 
Not 
required7 
 The Human Fertilisation and Embryology Authority? Yes No Not required7 
 The Home Office (in relation to personal and project licences, and certificates of designation)? Yes No7 
Not 
required 
 The Gene Therapy Advisory Committee? Yes No Not required7 
 The UK Xenotransplantation Interim Regulatory Authority? Yes No Not required7 
 Administration of Radioactive Substances Advisory Committee (ARSAC)? Yes No 
Not 
required7 
 Other bodies as appropriate? Please specify. 
 
e) Other Issues 
 
Are there any other details of which the Council should be aware? Yes No7 
 If yes, please give details. 
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Classification of Proposal 
a Theme and Priority Areas (mandatory) 
Indicate the theme and priority area of the committee selected that is relevant to the research proposal. 
Theme: AS: Integrative Animal Physiology (SYS) 
Priority Area(s)  
Main (Mandatory): AS: Genes to Physiology (FGIP) 
Secondary 1 (Optional): AS: Not in a Priority Area 
(b) Strategic Plan Objectives (mandatory) 
Indicate the strategic plan objectives to which the research proposal would contribute by ticking the appropriate tick-boxes 
(see definitions in the help file). Please apply one to five classifiers. 
Integrative 
Biology  
Sustainable 
Agriculture  
The Healthy 
Organism  
Bioscience For 
Industry  
Tools And 
Technology  
Animal welfare 
(experimental)  
Animal welfare 
(sustainability)  
Ageing (research 
to understand 
human ageing) 
 Biocatalysis  Analytical tools for the biosciences  
Chromosome 
structure and 
epigenetics 
 
Control of animal 
diseases 
(e.g.vaccinology) 
 
Integrative brain 
science and 
behaviour 
 Biomaterials  Bionanotechnology  
Communication 
and signalling  
Ecology of 
managed 
landscapes 
 Cloning  Bioprocessing  
E-science 
(including 
bioinformatics) 
 
Functional and 
comparative 
genomics 
 
Host/pathogen 
interactions - 
animals 
 
Diet and health 
in humans, 
including diet-
gene interactions
 Environmental biotechnology  
Genetic 
modification  
Genome 
sequencing  
Host/pathogen 
interactions - 
plants 
 
Normal (healthy) 
physiology and 
development 
(animals and 
humans) 
x 
Automated 
systems for high 
throughput 
 Genomics  
Integrative 
biology - animals x 
Modelling and 
epidemiology - 
animal disease 
 
Stem cells, 
including cell 
delivery and 
survival in 
transplants 
 
Industrial 
exploitation of 
plants and 
microbes, 
including 
secondary 
metabolism for 
bioindustry 
 GRID technology  
Integrative 
biology - 
microbes 
 
Modelling and 
epidemiology - 
plant disease 
 Tissue engineering  
Microbial food 
safety  
Mathematical 
models  
Integrative 
biology - plants  
Sustainable 
agriculture, 
including 
precision 
agriculture 
 Neuroscience  
Unculturable 
microorganisms 
for exploitation 
 Resources for proteomics  
Proteomics, 
including 
molecular 
structure and 
function 
determination 
 
Technologies for 
diagnosis of 
disease - 
animals 
   New pharmaceuticals  
Resources for 
metabolomics  
Transcriptomics   
Technologies for 
diagnosis of 
disease - plants 
     
Tools for structural 
biology, including 
high throughput 
techniques  
 
Metabolomics        Resources for transcriptomics  
Whole organism 
biology x         
(ii) Keywords (mandatory) 
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Keyword Research Topic Science Area 
Parturition Animal reproduction Animal science 
Pregnancy Animal reproduction Animal science 
Cardiovascular systems Animal and human physiology Animal science 
Integrative mammalian physiology Animal and human physiology Animal science 
Vessels Animal and human physiology Animal science 
Reproductive hormones Endocrinology Animal science 
Steroids Endocrinology Animal science 
Endocrine receptors Receptors Biomolecular science, biochemistry and chemical biology 
OTHER INFORMATION 
Reviewers (mandatory) 
1 Name Address Town Email Address 
Professor M Nielson Department of Anatomy and Physiology Frederiksberg mon@kvl.dk 
Keywords Mammary artery, mammary blood flow 
Reviewers (mandatory) 
2 Name Organisation Division or Department Email Address 
Professor Cherry Lindsey 
Wainwright 
The Robert Gordon 
University School of Pharmacy c.wainwright@rgu.ac.uk 
Keywords cardiovascular disease, cardiovascula pathology 
Reviewers (mandatory) 
3 Name Organisation Division or Department Email Address 
Professor John McGrath University of Glasgow Institute of Biomedical & Life Sciences I.McGrath@bio.gla.ac.uk 
Keywords cardiovascular disease, adrenoceptors, adventitia, nitric oxide, confocal microscopy 
Reviewers (mandatory) 
4 Name Organisation Division or Department Email Address 
Dr Alison Douglas University of Edinburgh Centre for Integrative Physiology alison.j.douglas@ed.ac.uk 
Keywords reproduction, lactation, weaning 
 
